Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.
Davis SN, Horton ES, Battelino T, Rubin RR, Schulman KA, Tamborlane WV. Davis SN, et al. Among authors: battelino t. Diabetes Technol Ther. 2010 Apr;12(4):249-55. doi: 10.1089/dia.2009.0145. Diabetes Technol Ther. 2010. PMID: 20210562 Free PMC article. Clinical Trial.
The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy.
Conget I, Battelino T, Giménez M, Gough H, Castañeda J, Bolinder J; SWITCH Study Group. Conget I, et al. Among authors: battelino t. Diabetes Technol Ther. 2011 Jan;13(1):49-54. doi: 10.1089/dia.2010.0107. Diabetes Technol Ther. 2011. PMID: 21175271 Free article. Clinical Trial.
Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study.
Nørgaard K, Scaramuzza A, Bratina N, Lalić NM, Jarosz-Chobot P, Kocsis G, Jasinskiene E, De Block C, Carrette O, Castañeda J, Cohen O; Interpret Study Group. Nørgaard K, et al. Diabetes Technol Ther. 2013 Apr;15(4):273-80. doi: 10.1089/dia.2012.0288. Epub 2013 Feb 25. Diabetes Technol Ther. 2013. PMID: 23438304 Free PMC article.
Technologies in diabetes--the fifth ATTD yearbook.
Battelino T, Phillip M. Battelino T, et al. Diabetes Technol Ther. 2014 Feb;16 Suppl 1:S2. doi: 10.1089/dia.2014.1500. Diabetes Technol Ther. 2014. PMID: 24479595 No abstract available.
Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Klein DJ, Battelino T, Chatterjee DJ, Jacobsen LV, Hale PM, Arslanian S; NN2211-1800 Study Group. Klein DJ, et al. Among authors: battelino t. Diabetes Technol Ther. 2014 Oct;16(10):679-87. doi: 10.1089/dia.2013.0366. Epub 2014 Jul 18. Diabetes Technol Ther. 2014. PMID: 25036533 Free PMC article. Clinical Trial.
Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study.
Hommel E, Olsen B, Battelino T, Conget I, Schütz-Fuhrmann I, Hoogma R, Schierloh U, Sulli N, Gough H, Castañeda J, de Portu S, Bolinder J; SWITCH Study Group. Hommel E, et al. Among authors: battelino t. Acta Diabetol. 2014 Oct;51(5):845-51. doi: 10.1007/s00592-014-0598-7. Epub 2014 Jul 19. Acta Diabetol. 2014. PMID: 25037251 Free PMC article. Clinical Trial.
377 results